Delivery Order SPE2DB22D3010-SPE2DB25FP1WM
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,495.82 firm fixed-price contract provides for the delivery of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 25, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,544.45 firm fixed-price contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,182.92 firm fixed-price contract is for the delivery of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a completion date of May 23, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,476.60 firm fixed-price contract is for the supply of JANUVIA 100 MG TABLET 90S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 30, 2024 and was awarded on September 27, 2024. There is no set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,867.08 firm fixed-price contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,594.32 firm fixed-price contract is for the delivery of JANUVIA 100 MG TABLET 1000S, a medication for the treatment of diabetes. The contract has an ultimate completion date of June 25, 2025 and is not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,665.38 contract is for the delivery of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of July 9, 2025 and is not set-aside. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a $11,982.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUVIA 25 MG TABLET 90S, a medication used to treat type 2 diabetes. The award has an ultimate completion date of April 8, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,502.24, is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product used in the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract has no set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,341.96, is for the supply of JANUVIA 100 MG TABLET 90S, a drug used to treat type 2 diabetes. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through May 30, 2024. AmerisourceBergen has a larger $999,999,999 IDC with the DLA Troop Support Medical, which...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP1WMDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,842.26 firm fixed-price contract is for the delivery of JANUVIA 100 MG TABLET 90S, a medication used in the treatment of diabetes. The contract has an ultimate completion date of March 12, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 3/11/25 |